The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Auron Therapeutics
Honoraria - Kura Oncology
Consulting or Advisory Role - Abbvie; Agios; Aptose Biosciences; Astellas Pharma; Blueprint Medicines; Calithera Biosciences; CTI; Daiichi Sankyo; Foghorn Therapeutics; Genentech; Genesis Pharmaceuticals; Gilead Sciences; Janssen; Jazz Pharmaceuticals; Menarini; Neoleukin Therapeutics; Novartis; Oncusp Therapeutics; Ono Pharmaceutical; Pinotbio; Servier; Syndax; Syros Pharmaceuticals
Research Funding - Eisai
Other Relationship - Cellectis; Epizyme
Overall survival by IDH2 mutant allele (R140 or R172) in patients with late-stage mutant-IDH2 relapsed or refractory acute myeloid leukemia treated with enasidenib or conventional care regimens in the phase 3 IDHENTIFY trial.
 
Stéphane De Botton
Honoraria - Abbvie; Astellas Pharma; Bristol-Myers Squibb; Jazz Pharmaceuticals; SERVIER
Consulting or Advisory Role - Bristol Myers Squibb Foundation; GlaxoSmithKline; SERVIER; Syndax
Speakers' Bureau - Abbvie; Astellas Pharma; Bristol-Myers Squibb; Jazz Pharmaceuticals
Research Funding - Auron Therapeutics; Forma Therapeutics
Travel, Accommodations, Expenses - Abbvie; SERVIER
 
Alberto Risueño
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Andre C. Schuh
Honoraria - Amgen; Celgene; Jazz Pharmaceuticals; Novartis; Pfizer
Research Funding - Agios; Amgen; Celgene; Pfizer
 
Bob Lowenberg
Stock and Other Ownership Interests - Frame Therapeutics
Consulting or Advisory Role - Abbvie; Agios; AIMM Therapeutics; Astellas Pharma; Astex Pharmaceuticals; Bristol Myers Squibb; Catamaran Bio; Celgene; Clear Creek Bio; GEMoaB; Kronos Bio; Oxford Biomedica; Roche; SERVIER
 
Hee-Je Kim
Honoraria - Abbvie; AIM BioSciences; Amgen; AML-Hub; Astellas Amgen BioPharama; Aston Sci.; Bristol-Myers Squibb/Celgene; Handok; Janssen; LG Chem; Novartis; Pfizer; Sanofi; ViGen Cell
Consulting or Advisory Role - Abbvie; AML-Hub; Astellas Pharma; Boryung; Bristol-Myers Squibb/Celgene; Daiichi Sankyo; Handok; Janssen; LG Chem; Novartis; Pfizer; Pin Therapeutics; SL VaxiGen; ViGen Cell
Speakers' Bureau - Genzyme
Research Funding - BL&H
 
Paresh Vyas
Honoraria - Abbvie; Astellas Pharma; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Pfizer
Research Funding - Celgene
Patents, Royalties, Other Intellectual Property - Patent for flow cytometric detection of leukaemic stem cells
 
Andrew H. Wei
Honoraria - Abbvie/Genentech; Amgen; Astellas Pharma; AstraZeneca; Celgene; Janssen Oncology; Macrogenics; Novartis; Pfizer; SERVIER
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Astellas Pharma; AstraZeneca; Celgene; Janssen; Macrogenics; Novartis; Pfizer; SERVIER
Speakers' Bureau - Abbvie/Genentech; Celgene/Bristol-Myers Squibb; Novartis
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Roche (Inst); Servier (Inst)
Patents, Royalties, Other Intellectual Property - AW is a former employee of the Walter and Eliza Hall Institute which receives milestone and royalty payments related to venetoclax, and is eligible for benefits related to these payments. AW receives payments from WEHI related to venetoclax
 
Eytan M. Stein
No Relationships to Disclose
 
Hartmut Dohner
Consulting or Advisory Role - Abbvie; Agios; Amgen; Astellas Pharma; AstraZeneca; Berlin-Chemie; Bristol-Myers Squibb/Celgene; Celgene; GEMoaB; Gilead Sciences; Janssen Oncology; Jazz Pharmaceuticals; Novartis; Syndax
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Jazz Pharmaceuticals (Inst); Kronos Bio (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - SERVIER
 
Amir Tahmasb Fathi
Consulting or Advisory Role - Abbvie; Agios; Amgen; Astellas Pharma; Blueprint Medicines; Bristol-Myers Squibb; Bristol-Myers Squibb; Daiichi Sankyo; Foghorn Therapeutics; Forty Seven; Genentech; Ipsen; Kite, a Gilead company; Kura Oncology; MorphoSys; MorphoSys; Novartis; Pfizer; Seagen; Takeda; Trillium Therapeutics; Trovagene
Research Funding - Abbvie (Inst); agios (Inst); Bristol-Myers Squibb (Inst); SERVIER (Inst); Takeda (Inst)
 
Courtney Denton Dinardo
Leadership - Notable Labs
Stock and Other Ownership Interests - Notable Labs
Honoraria - Abbvie; Agios; Bluebird Bio; Celgene; Foghorn Therapeutics; Genentech/Abbvie; Genmab; GlaxoSmithKline; Jazz Pharmaceuticals; Novartis; SERVIER; Takeda
Consulting or Advisory Role - Abbvie; Agios; Celgene; GlaxoSmithKline
Research Funding - Abbvie; AGIOS; Celgene; Cleave Therapeutics; Daiichi Sankyo; Foghorn Therapeutics; Immune-Onc Therapeutics; Jazz Pharmaceuticals
 
Patricia Martin Regueira
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Lilia Taningco
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Iryna Bluemmert
Employment - Bristol-Myers Squibb
 
Xin Yu
Employment - Bristol-Myers Squibb; Regeneron (I)
Stock and Other Ownership Interests - Bristol-Myers Squibb; Regeneron (I)
 
Wendy L. See
Employment - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb
 
Maroof Hasan
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb